Lu L, Walker D, Broxmeyer H E, Hoffman R, Hu W, Walker E
J Immunol. 1987 Sep 15;139(6):1823-9.
Monoclonal antibodies, My10 (HPCA-1) and major histocompatibility class II (HLA-DR), were used to enrich and phenotype normal human marrow colony-forming unit: granulocyte-macrophage (CFU-GM), burst-forming unit: erythroid (BFU-E), and multipotential colony-forming unit: granulocyte-erythroid-macrophage-megakaryocyte (CFU-GEMM) progenitor cells. Nonadherent low density T lymphocyte-depleted marrow cells were sorted on a Coulter Epics 753 dye laser flow cytometry system with the use of Texas Red-labeled anti-My10 and phycoerythrin conjugated anti-HLA-DR. Cells were separated into populations with nondetectable expression of antigens (DR-My10-) or with constant expression of one antigen and increasing densities of the other antigen. More than 98% of the CFU-GM, BFU-E, and CFU-GEMM were found in fractions containing cells expressing both HLA-DR and My10 antigens. The cloning efficiency (CE) of cells in the DR-My10- cell fraction was 0.01%. In the antigen-positive sorted fractions, the CE was highest (up to 47%) in the fractions of cells expressing high My10 and low DR (My10 DR+) antigens and was lowest (2.5%) in the fraction of cells expressing low My10 and low DR (My10+DR+) antigens. Populations of cells varying in the density of HLA-DR, but not My10, antigens varied in the proportion and types of progenitor cells present. When My10-positive cells were sorted for HLA-DR density expression, the CE for CFU-GM was similar in the DR+ and DR++ fractions, but most of the BFU-E and CFU-GEMM were found in the DR+ fraction. Within the CFU-GM compartment, most of the eosinophil progenitors were found in the DR+ fraction, whereas a greater proportion of macrophage progenitors were detected in the DR++ fraction. CFU-GM and BFU-E in the fractions of cells positive for DR and My10 were assessed for responsiveness to the effects of recombinant human tumor necrosis factor-alpha, recombinant human interferon-gamma, and prostaglandin E1. Colony formation from CFU-GM was suppressed by the three molecules, and colony formation by BFU-E was suppressed by recombinant human tumor necrosis factor-alpha and interferon-gamma and enhanced, in the presence of T lymphocyte-conditioned medium, by prostaglandin E1 in all antigen-positive fractions.(ABSTRACT TRUNCATED AT 400 WORDS)
单克隆抗体My10(HPCA-1)和主要组织相容性复合体II类(HLA-DR)用于富集正常人骨髓集落形成单位并对其进行表型分析,这些集落形成单位包括粒细胞-巨噬细胞集落形成单位(CFU-GM)、爆式红细胞集落形成单位(BFU-E)以及多能集落形成单位,即粒细胞-红细胞-巨噬细胞-巨核细胞集落形成单位(CFU-GEMM)祖细胞。将非贴壁的低密度T淋巴细胞去除的骨髓细胞,在Coulter Epics 753染料激光流式细胞仪系统上进行分选,使用Texas Red标记的抗My10和藻红蛋白偶联的抗HLA-DR。细胞被分离成抗原表达不可检测的群体(DR-My10-),或一种抗原持续表达而另一种抗原密度增加的群体。超过98%的CFU-GM、BFU-E和CFU-GEMM存在于同时表达HLA-DR和My10抗原的细胞组分中。DR-My10-细胞组分中的细胞克隆效率(CE)为0.01%。在抗原阳性分选组分中,表达高My10和低DR(My10 DR+)抗原的细胞组分中CE最高(达47%),而表达低My10和低DR(My10+DR+)抗原的细胞组分中CE最低(2.5%)。HLA-DR抗原密度不同但My10抗原密度相同的细胞群体,其存在的祖细胞比例和类型有所不同。当对My10阳性细胞按HLA-DR密度表达进行分选时,CFU-GM在DR+和DR++组分中的CE相似,但大部分BFU-E和CFU-GEMM存在于DR+组分中。在CFU-GM组分内,大多数嗜酸性粒细胞祖细胞存在于DR+组分中,而在DR++组分中检测到更大比例的巨噬细胞祖细胞。对DR和My10阳性细胞组分中的CFU-GM和BFU-E进行了对重组人肿瘤坏死因子-α、重组人干扰素-γ和前列腺素E1作用的反应性评估。这三种分子均抑制CFU-GM的集落形成,重组人肿瘤坏死因子-α和干扰素-γ抑制BFU-E的集落形成,在所有抗原阳性组分中,前列腺素E1在T淋巴细胞条件培养基存在的情况下增强BFU-E的集落形成。(摘要截断于400字)